8 Results for "

Activated T Subunit

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "Activated T Subunit" in MCE Product Catalog:

  • Targets Recommended:
Cat. No.: HY-153406
CAS No.: 956139-30-3
Purity:  99.64%
Research Areas:  

Others

Activated T Subunit can be used in the synthesis of exon jumping oligomer conjugates. The oligomer conjugates complement selected target sites in the human anti-muscular atrophy protein gene and induce exon 51 jumping. Activated T subunit can be used for research of muscular dystrophy .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-P9947
CAS No.: 214745-43-4

Target:  

Integrin

Research Areas:  

Others

Efalizumab is a targeted T cell modulator, and is a humanized monoclonal antibody of CD11a, the α subunit of LFA-1. Efalizumab inhibits T cell activation, cutaneous T cell trafficking, and T cell adhesion to keratinocytes, can be used for plaque psoriasis research .
loading...
    loading...
Cat. No.: HY-108738
CAS No.: 152923-56-3
Purity:  99.18%
Synonyms: Ro 24-7375
Daclizumab (Ro 24-7375) is a humanized, monoclonal antibody that blocks CD25 (α-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab inhibits effector T cell activation, regulatory T cell (Treg) expansion and survival, and activation-induced T-cell apoptosis. Daclizumab increases IL-2 bioavailability to bind to the intermediate-affinity IL-2R (IL-2R-IA), driving the expansion of anti-inflammatory CD56bright natural killer (NK) cells. Daclizumab can be used for multiple sclerosis and cancer research .
loading...
    loading...
Cat. No.: HY-P991424

Research Areas:  

Inflammation/Immunology

GSK2618960 is a human monoclonal antibody (mAb) targeting IL-7Ra/CD127. GSK2618960 inhibits IL-7-induced STAT5 phosphorylation. GSK2618960 enhances CD4 T cell proliferation response and increases CD83, CD86, and CD209 expression in PBMCs. GSK2618960 can be used for the research of autoimmune and allergic inflammatory diseases. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) .
loading...
    loading...
Cat. No.: HY-100686
CAS No.: 152273-12-6
Purity:  99.85%
Target:  

GABA Receptor

Research Areas:  

Neurological Disease

U93631 is a GABAA receptor inhibitor targeting the picrotoxin (HY-101391) site, which exhibits higher inhibitory potency in receptors lacking α subunits. U93631 blocks GABA-induced chloride currents, exerts a mild initial stimulatory effect on activated currents, but its activity decreases in β2T246F mutant receptors. U93631 can serve as a ligand for the convulsant site of GABAA receptors in relevant studies .
loading...
    loading...
Cat. No.: HY-153406A
CAS No.: 1155373-34-4
Research Areas:  

Others

(rac)-Activated T subunit is the racemate of Activated T Subunit (HY-153406). Activated T Subunit can be used in the synthesis of exon jumping oligomer conjugates. The oligomer conjugates complement selected target sites in the human anti-muscular atrophy protein gene and induce exon 51 jumping. (rac)-Activated T subunit can be used for research of muscular dystrophy .
loading...
    loading...
Cat. No.: HY-P705862
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: PRKACA; CDNA FLJ58698, Highly Similar To CAMP-Dependent Protein Kinase, Alpha-Catalytic Subunit; Protein Kinase CAMP-Activated Catalytic Subunit Alpha; Protein Kinase A Catalytic Subunit; CAMP-Dependent Protein Kinase Catalytic Subunit Alpha; Protein Kina
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-179499
CAS No.: 2978620-84-5
Research Areas:  

Cancer

PROTAC EZH2 Degrader-9 is orally active EZH2 PROTAC degrader degrading EZH2 via the ubiquitin-proteasome pathway. PROTAC EZH2 Degrader-9 downregulates PRC2 core subunits and potent inhibition of H3K27me3 without affecting common CRBN neosubstrates while it was selective over GSp'T1 and ikZF1/3. PROTAC EZH2 Degrader-9 exhibits potent antiproliferative activity against multiple cancer cell lines by inducing cell cycle and apoptosis. PROTAC EZH2 Degrader-9 reverses PRC2-mediated gene silencing and inhibiting EZH2 non-catalytic target gene activation. PROTAC EZH2 Degrader-9 can be used for leukemia, lymphoma, and non-small cell lung cancer research .
loading...
    loading...